<SEC-DOCUMENT>0001104659-21-122772.txt : 20211005
<SEC-HEADER>0001104659-21-122772.hdr.sgml : 20211005
<ACCEPTANCE-DATETIME>20211005065657
ACCESSION NUMBER:		0001104659-21-122772
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20211005
DATE AS OF CHANGE:		20211005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coterra Energy Inc.
		CENTRAL INDEX KEY:			0000858470
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		IRS NUMBER:				043072771
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-257534
		FILM NUMBER:		211305127

	BUSINESS ADDRESS:	
		STREET 1:		840 GESSNER ROAD, SUITE 1400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77024
		BUSINESS PHONE:		2815894600

	MAIL ADDRESS:	
		STREET 1:		840 GESSNER ROAD, SUITE 1400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CABOT OIL & GAS CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>tm2129008d1_posam.htm
<DESCRIPTION>POS AM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on October 4, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-257534&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POST-EFFECTIVE AMENDMENT NO. 1</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ON FORM S-3 TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ON FORM S-4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Under</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>THE SECURITIES ACT OF 1933</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Coterra Energy Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified in its
charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; text-align: center; width: 31%"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 33%"><FONT STYLE="font-size: 10pt"><B>1311</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>04-3072771</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or other jurisdiction of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>incorporation or organization)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Primary Standard Industrial</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Classification Code Number)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S. Employer</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification Number)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three Memorial City Plaza</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>840 Gessner Road, Suite 1400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Houston, Texas 77024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(281)&nbsp;589-4600</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address, including zip code, and telephone
number, including area code, of registrant&rsquo;s principal executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Scott C. Schroeder</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Executive Vice President and Chief Financial
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Coterra Energy Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three Memorial City Plaza</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>840 Gessner Road, Suite 1400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Houston, Texas 77024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(281) 589-4600</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name, address, including zip code, and telephone</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>number, including area code, of agent for service)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>With copies to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ted W. Paris</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Clinton W. Rancher</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Eileen S. Boyce</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Baker Botts L.L.P.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>910 Louisiana Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Houston, Texas 77002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(713) 229-1234</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Approximate date of commencement of proposed sale to the public:</B>&nbsp;&nbsp;&nbsp;&nbsp;From
time to time after the effective date of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the only securities being registered on this Form are to be offered
pursuant to dividend or interest reinvestment plans, please check the following box.&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following box.&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective
registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is a registration statement pursuant to General Instruction
I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under
the Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is a post-effective amendment to a registration statement
filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule
413(b) under the Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions
of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo; and &ldquo;emerging
growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#120;</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Title
                                            of each class of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>securities
                                            to be registered</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>to
                                            be<BR> registered</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Proposed<BR> maximum<BR>
    offering price<BR> per security</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed<BR>
                                            maximum<BR> aggregate</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>offering
                                            price</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount
                                            of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>registration
                                            fee</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Common Stock, par value $0.10
    per share</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: right; padding-bottom: 1pt; padding-left: 0.25pt">66,627
    (1)</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: right">(2</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: right">(2</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: right">(2</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">This Post-Effective Amendment No. 1  on Form S-3 relates
    to shares of common stock, par value $0.10 per share (&ldquo;Common Stock&rdquo;), of Coterra Energy Inc., a Delaware corporation
    (formerly known as Cabot Oil &amp; Gas Corporation) (the &ldquo;Registrant&rdquo;), issuable in the future under certain stock options
    outstanding pursuant to the Cimarex Energy Co. Amended and Restated 2019 Equity Incentive Plan and the Cimarex Energy Co. 2014 Equity
    Incentive Plan, each as amended to date, which options were assumed by the Registrant in connection with the merger involving Cimarex
    Energy Co., a Delaware corporation (&ldquo;Cimarex&rdquo;), on October 1, 2021 (the &ldquo;Merger&rdquo;) and which options were held by individuals who were
    not directors or employees of the Registrant immediately following the completion of the Merger. In accordance with Rule 416 under
    the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement also registers such additional
    shares of Common Stock and securities that may from time to time be offered or issued to prevent dilution resulting from stock splits,
    stock dividends or similar transactions. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">This Post-Effective Amendment No. 1  on Form S-3 covers
    the offering with respect to securities that was originally registered on the Registrant&rsquo;s Registration Statement on Form S-4
    (File No. 333-257534), which was filed on June 30, 2021, as amended, and was declared effective on August 20, 2021 (the &ldquo;Form
    S-4&rdquo;). All filing fees payable in connection with the issuance of these securities were previously paid in connection with
    the filing of the Form S-4. </FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Coterra Energy Inc., a Delaware corporation (formerly known as
Cabot Oil &amp; Gas Corporation) (the &ldquo;Registrant&rdquo;), hereby amends its Registration Statement on Form S-4 (File No.
333-257534), which was filed on June 30, 2021, as amended, and was declared effective on August 20, 2021 (the &ldquo;Form
S-4&rdquo;), by filing this Post-Effective Amendment No. 1 on Form S-3 to the Form S-4, containing an updated prospectus relating to
the offer and sale of up to 66,627 shares of the Registrant&rsquo;s common stock, par value $0.10 per share (&ldquo;Common
Stock&rdquo;), issuable upon the exercise of certain outstanding stock options (the &ldquo;Converted Options&rdquo;) that were
initially issued by Cimarex Energy Co., a Delaware corporation (&ldquo;Cimarex&rdquo;), under the Cimarex Energy Co. Amended and
Restated 2019 Equity Incentive Plan and the Cimarex Energy Co. 2014 Equity Incentive Plan (collectively, the &ldquo;Plans&rdquo;),
and that were assumed by the Registrant, to individuals who were not directors or employees of the Registrant immediately following
the effective time of the Merger, as defined below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October 1, 2021, the Registrant and Cimarex consummated a transaction
whereby Double C Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Registrant (&ldquo;Merger Sub&rdquo;),
merged with and into Cimarex (the &ldquo;Merger&rdquo;) as contemplated by, and in accordance with, the Agreement and Plan of Merger,
dated as of May 23, 2021, by and among the Registrant, Merger Sub and Cimarex (as amended on June 29, 2021, the &ldquo;Merger Agreement&rdquo;).
As a result of the Merger, Cimarex became a subsidiary of the Registrant. Pursuant to the terms of the Merger Agreement, at the effective
time of the Merger, certain outstanding awards issued under the Plans were assumed by the Registrant and converted into awards with respect
to Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;<IMG SRC="tm2129008d1_posamimg001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Coterra
Energy Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><BR>
66,627 Shares of Common Stock Underlying Options Previously Granted<BR>
 &nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus relates to up to 66,627 shares of common stock, par
value $0.10 per share (&ldquo;Common Stock&rdquo;), of Coterra Energy Inc. (the &ldquo;Registrant,&rdquo; &ldquo;Coterra,&rdquo; &ldquo;we,&rdquo;
 &ldquo;us&rdquo; or &ldquo;our&rdquo;). The shares of Common Stock are issuable upon the exercise of outstanding options held by former
directors or employees of Cimarex Energy Co. (&ldquo;Cimarex&rdquo;), which options were assumed by us in connection with the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will not receive any proceeds from the sale of shares of Common
Stock covered by this prospectus other than proceeds from the exercise of any options whose underlying shares of Common Stock are covered
by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Common Stock is listed on the New York Stock Exchange (&ldquo;NYSE&rdquo;)
under the symbol &ldquo;CTRA.&rdquo; On September 30, 2021, the last reported sale price of our Common Stock on the New York Stock Exchange
was $21.76 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You should carefully read and consider the risk factors included
in our periodic reports and other information that we file with the Securities and Exchange Commission before you invest in our securities.
See &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 4 of this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><B>Neither the Securities and Exchange Commission
the ("SEC") nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Prospectus dated October 4, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 88%; text-align: center"><FONT STYLE="font-size: 10pt"><B>TABLE OF CONTENTS </B></FONT></TD>
    <TD STYLE="width: 12%; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_001">SUMMARY</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_001">4</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_002">THE COMPANY&#9;</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_002">4</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_003">THE OFFERING</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_003">4</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_004">RISK FACTORS&#9;</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_004">4</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_005">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_005">4</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_006">USE OF PROCEEDS&#9;</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_006">5</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_007">DESCRIPTION OF THE PLAN&#9;</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_007">5</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_008">DESCRIPTION OF CAPITAL STOCK</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_008">5</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_009">PLAN OF DISTRIBUTION</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_009">5</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_010">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_010">5</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_011">LEGAL MATTERS</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_011">6</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#a_012">EXPERTS</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_012">6</A></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We have not authorized anyone to provide any information or to
make any representations other than those contained or incorporated by reference in this prospectus and any written communication prepared
by us or on our behalf.&nbsp; We take no responsibility for, and can provide no assurance as to the reliability of, any other information
that others may give you.&nbsp;You should not assume that the information provided in this prospectus or incorporated by reference in
this prospectus or in any such free writing prospectus we have authorized is accurate as of any date other than the date on the front
of this prospectus or the date of those documents. Our business, financial condition, results of operations and prospects may have changed
since those dates. This prospectus and any accompanying prospectus supplement constitute an offer to sell only under circumstances and
in jurisdictions where it is lawful to do so. </B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Split-Segment; Name: [split002] -->
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A>SUMMARY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt"><FONT STYLE="background-color: white"><I>This summary contains basic
information about us and this offering. Because it is a summary, it does not contain all of the information that you should consider
before investing in our Common Stock. You should read this entire prospectus and the documents incorporated by reference carefully, including
the section entitled &ldquo;Risk Factors&rdquo; in our Annual Report on Form&nbsp;10-K&nbsp;and any updates to such risks in subsequently
filed Quarterly Reports on Form&nbsp;10-Q&nbsp;and our financial statements and the notes thereto incorporated by reference into this
prospectus supplement before making an investment decision.</I></FONT><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_002"></A>THE COMPANY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a premier, diversified energy company engaged in the
development, exploitation, exploration and production of oil and gas properties exclusively onshore in the United States. Our assets
are concentrated in the Marcellus Shale, Permian Basin and Mid-Continent Region. Our Common Stock is listed on the NYSE under the
symbol &ldquo;CTRA.&rdquo; Our principal executive office is located at Three Memorial City Plaza, 840 Gessner Road, Suite 1400,
Houston, Texas 77024, and our telephone number at that address is (281)&nbsp;589-4600. <FONT STYLE="background-color: white">For
further discussion of the material elements of our business, please refer to our </FONT>most recent Annual Report on Form 10-K <FONT STYLE="background-color: white">and
any subsequent reports we file with the SEC, which are incorporated by reference in this prospectus.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_003"></A>THE OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt; width: 27%"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="padding: 0.25pt; vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt; width: 71%"><FONT STYLE="font-size: 10pt">Coterra Energy Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Shares offered</FONT></TD>
    <TD STYLE="padding: 0.25pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Up to 66,627 shares of Common Stock,
    par value $0.10 per share.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="padding: 0.25pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">We will not receive any proceeds
    from the sale of our common shares covered by this prospectus other than proceeds from the exercise of the Converted Options as to
    which the underlying shares are covered by this prospectus. We have no plans for the application of any of these proceeds other than
    for general corporate purposes.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">New York Stock Exchange Symbol</FONT></TD>
    <TD STYLE="padding: 0.25pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">&ldquo;CTRA&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_004"></A>RISK FACTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investing in the securities to be offered by this prospectus and any
applicable prospectus supplement involves risk. Before you make a decision to buy our securities, you should read and carefully consider
the risks and uncertainties discussed under &ldquo;Forward-Looking Statements&rdquo; and the risk factors set forth in our most recent
Annual Report on Form 10-K, and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K filed with the SEC prior
to the date of this prospectus, and in the documents and reports that we file with the SEC after the date of this prospectus that are
incorporated by reference into this prospectus, as well as any risks described in any applicable prospectus supplement and any related
free writing prospectus or in other documents that are incorporated by reference therein. Additional risks not currently known to us
or that we currently deem immaterial may also have a material adverse effect on us.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_005"></A>CAUTIONARY STATEMENT
REGARDING FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The statements contained in this prospectus and any related
prospectus supplement, or incorporated by reference in this prospectus and any related prospectus supplement, or in any permitted
free writing prospectuses we have authorized for use with respect to the applicable offering or transaction, that are not purely
historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the
 &ldquo;Securities Act&rdquo;), and Section 21E of Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
including statements regarding <FONT STYLE="background-color: white">future financial and operating performance and results,
strategic pursuits and goals, market prices, future hedging and risk management activities. The words &ldquo;expect,&rdquo;
 &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;budget,&rdquo;
 &ldquo;plan,&rdquo; &ldquo;forecast,&rdquo; &ldquo;target,&rdquo; &ldquo;predict,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo;
 &ldquo;could,&rdquo; &ldquo;will&rdquo; and similar expressions are also intended to identify forward-looking statements. Such
statements involve risks and uncertainties, including, but not limited to, the continuing effects of the COVID-19 pandemic and the
impact thereof on our business, financial condition and results of operations, the availability of cash on hand and other sources of
liquidity to fund our capital expenditures, actions by, or disputes among or between, members of the Organization of Petroleum
Exporting Countries and other exporting nations (OPEC+), market factors, market prices (including geographic basis differentials) of
natural gas, results of future drilling and marketing activity, future production and costs, legislative and regulatory initiatives,
the integration of the merger of Cimarex Energy Co. and Coterra, electronic, cyber or physical security breaches and other
factors detailed herein and in our other SEC filings. Should one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_006"></A>USE OF PROCEEDS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will not receive any proceeds from the sale of our Common
Stock covered by this prospectus other than proceeds from the exercise, unless net-exercised as described below, of the Converted
Options whose underlying shares of Common Stock are covered by this prospectus. We have no plans for the application of any of these
proceeds other than for general corporate purposes. We have no assurance that any of such Converted Options will be exercised.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_007"></A>DESCRIPTION OF THE PLANS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The descriptions of the </FONT>Cimarex
Energy Co. Amended and Restated 2019 Equity Incentive Plan and the Cimarex Energy Co. 2014 Equity Incentive Plan set forth in Exhibits
99.1 and 99.2 hereto are hereby incorporated by reference.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_008"></A>DESCRIPTION OF CAPITAL
STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The description of our Common Stock, par value $0.10 per share, contained
under the heading &ldquo;Comparison of Stockholders&rsquo; Rights&rdquo; in the Form S-4 is hereby incorporated by reference.</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_009"></A>PLAN OF DISTRIBUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are registering 66,627 shares of Common Stock issuable upon the
exercise of the Converted Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the applicable options, our shares will be
issued to those option holders who elect to exercise and provide payment of the exercise price, including through a &ldquo;net exercise&rdquo;
of a number of shares otherwise deliverable in respect of the Converted Options. We do not know if or when the Converted Options will
be exercised. We also do not know whether any of the shares acquired upon exercise of any Converted Options will subsequently be resold.
We are not using an underwriter in connection with this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_010"></A>WHERE YOU CAN FIND MORE
INFORMATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We file annual, quarterly and current reports, proxy statements and
other business and financial information with the SEC. Our SEC filings are available to the public at the internet website maintained
by the SEC at <I>www.sec.gov</I>. You will also be able to obtain many of these documents, free of charge, from us by accessing our website
at <I>http://www.coterra.com</I> under the &ldquo;Investor Relations&rdquo; link and then the &ldquo;SEC Filings&rdquo; link.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SEC allows us to &ldquo;incorporate by reference&rdquo; the information
we have filed with it, which means that we can disclose important information to you by referring you to those documents. The information
we incorporate by reference is an important part of this prospectus, and later information that we file with the SEC will automatically
update and supersede this information. We incorporate by reference the documents listed below and any future filings we make with the
SEC under Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (excluding any information furnished pursuant to Item&nbsp;2.02
or Item&nbsp;7.01 of any Current Report on Form 8-K) until the termination of each offering under this prospectus. The documents we incorporate
by reference include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 6%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 90%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000085847021000013/cog-20201231.htm" STYLE="-sec-extract: exhibit">Registrant&rsquo;s
    Annual Report on Form 10-K for the fiscal year ended December 31, 2020;</A> </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 6%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 90%; padding-bottom: 6pt; font-size: 10pt">Registrant&rsquo;s Quarterly Reports on Form 10-Q
    for the quarterly periods ended <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000085847021000022/cog-20210331.htm" STYLE="-sec-extract: exhibit">March
    31, 2021</A> and <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000085847021000049/cog-20210630.htm" STYLE="-sec-extract: exhibit">June
    30, 2021;</A> </TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Registrant&rsquo;s Current Reports on Form 8-K filed with the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000085847021000019/cog-20210429.htm" STYLE="-sec-extract: exhibit">April
    30, 2021</A> (<A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000085847021000023/cog-20210429.htm" STYLE="-sec-extract: exhibit">Two
    Filings</A>), <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921070785/tm2117344d1_8k.htm" STYLE="-sec-extract: exhibit">May
    24, 2021</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921082736/tm2117344d16_8k.htm" STYLE="-sec-extract: exhibit">June
    17, 2021</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921113817/tm2127139d1_8k.htm" STYLE="-sec-extract: exhibit">September
    8, 2021</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921116931/tm2127863d1_8k.htm" STYLE="-sec-extract: exhibit">September
    17, 2021</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921120825/tm2127863d4_8k.htm" STYLE="-sec-extract: exhibit">September
    29, 2021</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921122041/tm2129019d1_8k.htm" STYLE="-sec-extract: exhibit">October
    1, 2021</A>; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 6%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 90%; font-size: 10pt"><FONT STYLE="font-size: 10pt">The description of Registrant&rsquo;s
    common stock, par value $0.10 per share, contained in Registrant&rsquo;s Registration Statement on Form 8-A filed on January 24,
    1990, as amended by the Current Reports on Form 8-K filed on <A HREF="http://www.sec.gov/Archives/edgar/data/858470/000119312510011055/d8k.htm" STYLE="-sec-extract: exhibit">January&nbsp;22,
    2010</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/858470/000130817915000045/lcog_8k.htm" STYLE="-sec-extract: exhibit">March&nbsp;12,
    2015</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/858470/000085847016000059/cog063020168k.htm" STYLE="-sec-extract: exhibit">July&nbsp;29,
    2016</A>(<A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465916135237/a16-15636_18k.htm" STYLE="-sec-extract: exhibit">Two
    Filings</A>),<A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921070785/tm2117344d1_8k.htm" STYLE="-sec-extract: exhibit">
    May&nbsp;24, 2021</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000110465921082736/tm2117344d16_8k.htm" STYLE="-sec-extract: exhibit">June&nbsp;17,
    2021</A>, and any other amendment or report filed for the purpose of updating such description; and</FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">The Unaudited Pro Forma Combined
    Financial Data of the Registrant and Cimarex, contained in Registrant&rsquo;s Registration Statement on Form S-4 filed on <A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486-1_s4.htm" STYLE="-sec-extract: exhibit">June
    29, 2021</A>, as amended on <A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921104699/tm2120486-3_s4a.htm" STYLE="-sec-extract: exhibit">August
    13, 2021</A>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All documents subsequently filed by the Registrant pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment that indicates that all
securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by
reference in this Registration Statement and to be part hereof from the respective date of filing of such documents (other than
current reports furnished under Item 2.02 and Item 7.01 of Form 8-K).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You may request a copy of these filings, other than an exhibit to
these filings unless we have specifically incorporated that exhibit by reference into the filing, at no cost, by writing or telephoning
the Registrant at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Coterra Energy Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Three Memorial City Plaza</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">840 Gessner Road, Suite 1400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Houston, Texas 77024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attention: Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Telephone: (281) 589-4600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_011"></A>LEGAL MATTERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The validity of the shares of Common Stock offered
hereby have been passed upon for us by Baker Botts L.L.P., Houston, Texas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_012"></A>EXPERTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The consolidated financial statements and management&rsquo;s assessment
of the effectiveness of internal control over financial reporting (which is included in Management&rsquo;s Report on Internal Control
over Financial Reporting) incorporated in this prospectus by reference to the <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/858470/000085847021000013/cog-20201231.htm" STYLE="-sec-extract: exhibit">Annual
Report on Form 10-K for the year ended December&nbsp;31, 2020</A> have been so incorporated in reliance on the report of PricewaterhouseCoopers
LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Estimates of the proved reserves of the Registrant and related future
net revenues included in the Registrant&rsquo;s Annual Report on Form 10-K for the year ended December&nbsp;31, 2020 were subject to
an audit performed by Miller and Lents, Ltd., an independent petroleum engineer. Miller and Lents, Ltd. prepared independent estimates
of 100&nbsp;percent of the proved reserves reported by the Registrant and found that such estimates were within 10&nbsp;percent of the
Registrant&rsquo;s reported proved reserves. Estimates of proved reserves and related future net revenues prepared by the Registrant
have been so incorporated in this prospectus in reliance on the authority of such firm as experts in such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The consolidated financial statements of Cimarex Energy Co. as of
December 31, 2020 and 2019, and for each of the years in the three-year period ended December 31, 2020, and management's assessment
of the effectiveness of internal control over financial reporting as of December 31, 2020 incorporated by reference herein in
reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the
authority of said firm as experts in accounting and auditing. The audit report covering the December 31, 2020 consolidated financial
statements refers to a change in the method of accounting for leases in 2019 due to the adoption of Financial Accounting Standards
Board Accounting Standards Codification Topic 842,&nbsp;<I>Leases</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DeGolyer and MacNaughton, an independent petroleum engineering firm,
reviewed Cimarex&rsquo;s proved reserve estimates for properties comprising at least 80% of the total future net revenue discounted at
10% attributable to the total interests held by Cimarex as of December&nbsp;31, 2020. Estimated quantities of Cimarex&rsquo;s oil and
gas reserves and the net present value of such reserves have been included and incorporated by reference in this prospectus in reliance
on the authority of said firm as experts in petroleum engineering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>Item&nbsp;14.</B></TD><TD><B>Other Expenses of Issuance and Distribution </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth expenses payable by the Registrant
in connection with the issuance and distribution of the securities being registered. All the amounts shown are estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">SEC registration fee</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">*</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Printing expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Legal fees and expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Accounting fees and expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Miscellaneous</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">10,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 0.5in">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">* Previously paid
in connection with the original filing of this Registration Statement on Form S-4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Split-Segment; Name: [split003] -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"><B>Item&nbsp;15.</B></TD><TD STYLE="text-align: left"><B>Indemnification of Directors and
                                            Officers </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Section 145 of the General Corporation Law of the
State of Delaware (the &ldquo;DGCL&rdquo;) empowers a Delaware corporation to indemnify any person who was or is a party or is threatened
to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of such corporation) by reason of the fact that such person is or was a director or officer,
employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or other enterprise. The indemnity may include expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action,
suit or proceeding, provided that he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests
of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.
A Delaware corporation may indemnify directors, officers, employees and others in an action by or in the right of the corporation under
the same conditions, except that no indemnification is permitted without judicial approval if the person to be indemnified has been adjudged
to be liable to the corporation. Where a director or officer is successful on the merits or otherwise in the defense of any action referred
to above or in defense of any claim, issue or matter therein, the corporation must indemnify such director or officer against the expenses
(including attorneys&rsquo; fees) which he or she actually and reasonably incurred in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Section 40 of the Coterra bylaws provides for indemnification
of Coterra&rsquo;s directors and officers to the full extent permitted by law, as now in effect or later amended. Section 40 of the Coterra
bylaws provides that expenses incurred by a director or officer in defending a suit or other similar proceeding shall be paid by Coterra
upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it is ultimately determined that such
director or officer is not entitled to be indemnified by Coterra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Additionally, the Coterra certificate of incorporation
contains a provision that limits the liability of Coterra&rsquo;s directors to the fullest extent permitted by the DGCL. The provision
eliminates the personal liability of Coterra&rsquo;s directors or the Coterra stockholders for monetary damages for breach of the director&rsquo;s
fiduciary duty of care as a director. As a result, Coterra stockholders may be unable to recover monetary damages against directors for
negligent or grossly negligent acts or omissions in violation of their duty of care. The provision does not change the liability of a
director for breach of his duty of loyalty to Coterra or to the Coterra stockholders, for acts or omissions not in good faith or which
involve intentional misconduct or a knowing violation of law, for the declaration or payment of dividends in violation of Delaware law,
or in respect of any transaction from which a director receives an improper personal benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In addition to the indemnification provisions in
the Coterra certificate of incorporation and the Coterra bylaws, Coterra has taken such other steps as are reasonably necessary to effect
its indemnification policy. Included among such other steps is liability insurance provided by Coterra for its directors and officers
for certain losses arising from claims or charges made against them in their capacities as directors or officers of Coterra. Coterra
has also entered into indemnity agreements with individual officers. These agreements generally provide such officers with a contractual
right to indemnification to the full extent provided by applicable law and the Coterra bylaws as in effect at the respective dates of
such agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Coterra has placed in effect insurance which purports
(1) to insure it against certain costs of indemnification which may be incurred by it pursuant to the aforementioned Coterra bylaws provision
or otherwise and (2) to insure Coterra&rsquo;s officers and directors and of specified subsidiaries against certain liabilities incurred
by them in the discharge of their functions as officers and directors except for liabilities arising from their own malfeasance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"><B>Item&nbsp;16.</B></TD><TD STYLE="text-align: left"><B>Exhibits</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The exhibits listed below are filed or incorporated
by reference as part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 0; text-align: left; width: 8%"><B>Exhibit No.</B></TD>
                                                                                               <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 0; text-align: left; width: 92%"><B>Description</B></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left; width: 5%"><A HREF="https://www.sec.gov/Archives/edgar/data/858470/000110465921122041/tm2129019d1_ex3-1.htm" STYLE="-sec-extract: exhibit">3.1*</A></TD><TD STYLE="padding-bottom: 0; text-align: left; width: 3%"><A HREF="https://www.sec.gov/Archives/edgar/data/858470/000110465921122041/tm2129019d1_ex3-1.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left; width: 92%"><A HREF="https://www.sec.gov/Archives/edgar/data/858470/000110465921122041/tm2129019d1_ex3-1.htm" STYLE="-sec-extract: exhibit">Restated
                                            Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit
                                            3.3 to the Company&rsquo;s Current Report on Form 8-K filed with the SEC on October 1, 2021).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/858470/000110465921122041/tm2129019d1_ex3-2.htm" STYLE="-sec-extract: exhibit">3.2*</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/858470/000110465921122041/tm2129019d1_ex3-2.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/858470/000110465921122041/tm2129019d1_ex3-2.htm" STYLE="-sec-extract: exhibit">Amended
                                            and Restated Bylaws of the Registrant (incorporated herein by reference to Exhibit 3.4 to
                                            the Company&rsquo;s Current Report on Form 8-K filed with the SEC on October 1, 2021).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921122597/tm2129020d1_ex4-3.htm" STYLE="-sec-extract: exhibit">4.1*</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921122597/tm2129020d1_ex4-3.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921122597/tm2129020d1_ex4-3.htm" STYLE="-sec-extract: exhibit">Form
                                            of Common Stock Certificate of the Registrant (incorporated herein by reference to Exhibit
                                            4.3 to the Registration Statement on Form S-8 of the Registrant (Registration
                                            No. 333-260035)).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486d2_ex5-1.htm" STYLE="-sec-extract: exhibit">5.1*</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486d2_ex5-1.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486d2_ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion
                                            of Baker Botts L.L.P. (incorporated by reference to Exhibit 5.1 to the Registration Statement
                                            on Form S-4 of the Registrant (Registration No. 333-257534)).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1168054/000110465921069859/tm2117043d1_ex99-1.htm" STYLE="-sec-extract: exhibit">10.1*</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1168054/000110465921069859/tm2117043d1_ex99-1.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1168054/000110465921069859/tm2117043d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Cimarex
                                            Energy Co. Amended and Restated 2019 Equity Incentive Plan (incorporated by reference to
                                            Exhibit 99.1 to the Registration Statement on Form S-8 of Cimarex (Registration No. 333-256323)).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1168054/000110465914024742/a14-2296_2def14a.htm" STYLE="-sec-extract: exhibit">10.2*</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1168054/000110465914024742/a14-2296_2def14a.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1168054/000110465914024742/a14-2296_2def14a.htm" STYLE="-sec-extract: exhibit">Cimarex
                                            Energy Co. 2014 Equity Incentive Plan (incorporated by reference to Appendix A to the Definitive
                                            Proxy Statement on Schedule 14A of Cimarex filed with the SEC on April 1, 2014).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486d2_ex5-1.htm" STYLE="-sec-extract: exhibit">23.1</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486d2_ex5-1.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486d2_ex5-1.htm" STYLE="-sec-extract: exhibit">Consent
                                            of Baker Botts L.L.P. (contained in Exhibit 5.1).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-2.htm" STYLE="-sec-extract: exhibit">23.2</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-2.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-2.htm" STYLE="-sec-extract: exhibit">Consent
                                            of PricewaterhouseCoopers LLP.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-3.htm" STYLE="-sec-extract: exhibit">23.3</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-3.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-3.htm" STYLE="-sec-extract: exhibit">Consent
                                            of KPMG LLP.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-4.htm" STYLE="-sec-extract: exhibit">23.4</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-4.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-4.htm" STYLE="-sec-extract: exhibit">Consent
                                            of Miller and Lents, Ltd.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-5.htm" STYLE="-sec-extract: exhibit">23.5</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-5.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex23-5.htm" STYLE="-sec-extract: exhibit">Consent
                                            of DeGolyer and MacNaughton.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486-1_s4.htm#tSIG" STYLE="-sec-extract: exhibit">24.1*</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486-1_s4.htm#tSIG" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/858470/000110465921087023/tm2120486-1_s4.htm#tSIG" STYLE="-sec-extract: exhibit">Powers
                                            of Attorney (incorporated by reference to Exhibit 99.1 to the Registration Statement on Form
                                            S-4 of the Registrant (Registration No. 333-257534)).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                                <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex99-1.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Summary
                                            of Cimarex Energy Co. 2014 Equity Incentive Plan.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex99-2.htm" STYLE="-sec-extract: exhibit">99.2</A></TD><TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex99-2.htm" STYLE="-sec-extract: exhibit">&mdash;</A></TD>
                                                                                               <TD STYLE="padding-bottom: 0; text-align: left"><A HREF="tm2129008d1_ex99-2.htm" STYLE="-sec-extract: exhibit">Summary
                                            of Cimarex Energy Co. Amended and Restated 2019 Equity Incentive Plan.</A></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 17.3pt">*</TD><TD STYLE="text-align: left">Incorporated by reference to the indicated filing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"><B>Item&nbsp;17.</B></TD><TD STYLE="text-align: left"><B>Undertakings </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned Registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 24.45pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(1)</TD><TD STYLE="text-align: left">To
                                            file, during any period in which offers or sales are being made, a post-effective amendment
                                            to this Registration Statement:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 48.85pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(i)</TD><TD STYLE="text-align: left">To
                                            include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 48.85pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(ii)</TD><TD STYLE="text-align: left">To
                                            reflect in the prospectus any facts or events arising after the effective date of the registration
                                            statement (or the most recent post-effective amendment thereof) which, individually or in
                                            the aggregate, represent a fundamental change in the information set forth in the registration
                                            statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
                                            offered (if the total dollar value of securities offered would not exceed that which was
                                            registered) and any deviation from the low or high end of the estimated maximum offering
                                            range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
                                            424(b) if, in the aggregate, the changes in volume and price represent no more than a 20%
                                            change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration
                                            Fee&rdquo; table in the effective registration statement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 48.85pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(iii)</TD><TD STYLE="text-align: left">To
                                            include any material information with respect to the plan of distribution not previously
                                            disclosed in the registration statement or any material change to such information in the
                                            registration statement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>provided, however</I>, that paragraphs (1)(i),
(1)(ii)&nbsp;and (1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the Commission by a registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the
Exchange Act, that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant
to Rule 424(b) that is part of the registration statement.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 24.45pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(2)</TD><TD STYLE="text-align: left">That,
                                            for the purpose of determining any liability under the Securities Act, each such post-effective
                                            amendment shall be deemed to be a new registration statement relating to the securities offered
                                            therein, and the offering of such securities at that time shall be deemed to be the initial
                                            bona fide offering thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 24.45pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(3)</TD><TD STYLE="text-align: left">To
                                            remove from registration by means of a post-effective amendment any of the securities being
                                            registered which remain unsold at the termination of the offering.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 24.45pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(4)</TD><TD STYLE="text-align: left">That,
                                            for the purpose of determining liability under the Securities Act to any purchaser:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 48.85pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(A)</TD><TD STYLE="text-align: left">Each
                                            prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part
                                            of the registration statement as of the date the filed prospectus was deemed part of and
                                            included in the registration statement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 48.85pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(B)</TD><TD STYLE="text-align: left">Each
                                            prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a
                                            registration statement in reliance on Rule 430B relating to an offering made pursuant to
                                            Rule 415(a)(1)(i), (vii)&nbsp;or (x)&nbsp;for the purpose of providing the information required
                                            by Section&nbsp;10(a) of the Securities Act shall be deemed to be part of and included in
                                            the registration statement as of the earlier of the date such form of prospectus is first
                                            used after effectiveness or the date of the first contract of sale of securities in the offering
                                            described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer
                                            and any person that is at that date an underwriter, such date shall be deemed to be a new
                                            effective date of the registration statement relating to the securities in the registration
                                            statement to which that prospectus relates, and the offering of such securities at that time
                                            shall be deemed to be the initial bona fide offering thereof. Provided, however, that no
                                            statement made in a registration statement or prospectus that is part of the registration
                                            statement or made in a document incorporated or deemed incorporated by reference into the
                                            registration statement or prospectus that is part of the registration statement will, as
                                            to a purchaser with a time of contract of sale prior to such effective date, supersede or
                                            modify any statement that was made in the registration statement or prospectus that was part
                                            of the registration statement or made in any such document immediately prior to such effective
                                            date.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 24.45pt"></TD><TD STYLE="text-align: left; width: 24.5pt">(5)</TD><TD STYLE="text-align: left">That,
                                            for the purpose of determining liability of the Registrant under the Securities Act to any
                                            purchaser in the initial distribution of the securities:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The undersigned registrant undertakes that in a
primary offering of securities of the undersigned registrant pursuant to the registration statement, regardless of the underwriting method
used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities
to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 49.5pt"></TD><TD STYLE="text-align: left; width: 22.5pt">(i)</TD><TD STYLE="text-align: left">Any
                                            preliminary prospectus or prospectus of the undersigned registrant relating to the offering
                                            required to be filed pursuant to Rule 424;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 49.5pt"></TD><TD STYLE="text-align: left; width: 22.5pt">(ii)</TD><TD STYLE="text-align: left">Any
                                            free writing prospectus relating to the offering prepared by or on behalf of the undersigned
                                            registrant or used or referred to by the undersigned registrant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 49.5pt"></TD><TD STYLE="text-align: left; width: 22.5pt">(iii)</TD><TD STYLE="text-align: left">The
                                            portion of any other free writing prospectus relating to the offering containing material
                                            information about the undersigned registrant or its securities provided by or on behalf of
                                            the undersigned registrant; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 49.5pt"></TD><TD STYLE="text-align: left; width: 22.5pt">(iv)</TD><TD STYLE="text-align: left">Any
                                            other communication that is an offer in the offering made by the undersigned registrant to
                                            the purchaser.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 22.5pt">(b)</TD><TD STYLE="text-align: left">The undersigned
                                            registrant hereby further undertakes that, for purposes of determining any liability under
                                            the Securities Act, each filing of the Registrant&rsquo;s annual report pursuant to Section&nbsp;13(a)
                                            or Section&nbsp;15(d) of the Exchange Act (and, where applicable, each filing of an employee
                                            benefit plan&rsquo;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that
                                            is incorporated by reference in the registration statement shall be deemed to be a new registration
                                            statement relating to the securities offered therein, and the offering of such securities
                                            at that time shall be deemed to be the initial bona fide offering thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 22.5pt">(c)</TD><TD STYLE="text-align: left">Insofar
                                            as indemnification for liabilities arising under the Securities Act may be permitted to directors,
                                            officers and controlling persons of the Registrant pursuant to the foregoing provisions,
                                            or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange
                                            Commission such indemnification is against public policy as expressed in the Securities Act
                                            and is, therefore, unenforceable. In the event that a claim for indemnification against such
                                            liabilities (other than the payment by a registrant of expenses incurred or paid by a director,
                                            officer or controlling person of such registrant in the successful defense of any action,
                                            suit or proceeding) is asserted by such director, officer or controlling person in connection
                                            with the securities being registered, such registrant will, unless in the opinion of its
                                            counsel the matter has been settled by controlling precedent, submit to a court of appropriate
                                            jurisdiction the question whether such indemnification by it is against public policy as
                                            expressed in the Securities Act and will be governed by the final adjudication of such issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Pursuant to the requirements of the Securities
Act of 1933, Coterra Energy Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing this Post-Effective Amendment No. 1 on Form S-3 to the Registration Statement on Form S-4 and has duly caused this
Post-Effective Amendment No. 1 to such Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Houston, State of Texas, on October 4, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">COTERRA ENERGY INC.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 47%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left; vertical-align: top; font-size: 10pt">/s/ Thomas E. Jorden</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Thomas E. Jorden</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Chief Executive Officer, President
    and Director</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Each person whose signature appears below constitutes
and appoints each of Thomas E. Jorden, Scott C. Schroeder, Francis B. Barron, Todd M. Roemer and Deidre L. Shearer, as his or her true
and lawful attorney or attorney-in-fact and agent, with full power to act with or without the others and with full power of substitution
and resubstitution, to execute in his or her name, place and stead, in any and all capacities, any or all amendments (including post-effective
amendments) to this Registration Statement and any registration statement for the same offering filed pursuant to Rule 462 under the
Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents and each of them full power and authority, to
do and perform in the name and on behalf of the undersigned, in any and all capacities, each and every act and thing necessary or desirable
to be done in and about the premises, to all intents and purposes and as fully as they might or could do in person, hereby ratifying
and confirming all that said attorneys-in-fact and agents or their substitutes may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Pursuant to the requirements of the Securities Act
of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on October 4, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 36%"><P STYLE="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Signature</B>&nbsp;</P></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 46%"><P STYLE="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Title</B>&nbsp;</P></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 15%"><P STYLE="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date</B>&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="text-align: center"></TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">/s/
                                            Thomas E. Jorden&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Thomas E. Jorden</B>&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Chief Executive Officer,
    President and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Director (Principal
    Executive Officer)</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><P STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">/s/
                                            <FONT STYLE="font-style: normal; font-weight: normal">Scott C. Schroeder&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Scott C. Schroeder</B>&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Executive Vice President and Chief Financial Officer
    (Principal Financial Officer)</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">/s/
                                                        Todd M. Roemer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;Todd M. Roemer&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Vice President and Chief Accounting Officer (Principal
    Accounting Officer)</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><P STYLE="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">*&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Dan O. Dinges&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Executive Chairman</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Dorothy M. Ables</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Dorothy
                                            M. Ables&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Robert S. Boswell</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Robert
                                            S. Boswell</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: center; vertical-align: top">/s/ Amanda M. Brock</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top; width: 36%"><!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 0.75pt solid; text-align: center; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Amanda M. Brock</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 46%"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 15%"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Paul N. Eckley</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 0.75pt solid; text-align: center; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Paul N. Eckley</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Hans Helmerich</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 0.75pt solid; text-align: center; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Hans Helmerich</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Lisa A. Stewart</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 0.75pt solid; text-align: center; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Lisa A. Stewart</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Frances M. Vallejo</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top"><!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: black 0.75pt solid; text-align: center; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Frances M. Vallejo</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; padding-bottom: 1pt">/s/ Marcus A. Watts</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left"><!-- Field: Rule-Page --><DIV STYLE="text-align: left; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: Black 0.5pt solid; text-align: left; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Marcus A. Watts</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;October 4, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in">*</TD><TD STYLE="text-align: left">The undersigned,
                                            by signing his name hereto, does hereby sign this Registration Statement on behalf of the
                                            directors of the Registrant in front of whose name asterisks appear, pursuant to powers of
                                            attorney duly executed by such directors and filed with the Commission.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; width: 3%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">By:</P></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left; vertical-align: top; width: 47%">/s/ Todd M. Roemer</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Todd M. Roemer</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Attorney-in-Fact</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>



<P STYLE="margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>2
<FILENAME>tm2129008d1_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Coterra Energy Inc. (formerly known
as Cabot Oil &amp; Gas Corporation) of our report dated February 26, 2021 relating to the financial statements and the effectiveness of
internal control over financial reporting, which appears in Cabot Oil &amp; Gas Corporation's Annual Report on Form 10-K for the year
ended December 31, 2020. We also consent to the reference to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ PricewaterhouseCoopers LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Houston, Texas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">October 4, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>3
<FILENAME>tm2129008d1_ex23-3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We consent to the use of our reports dated February&nbsp;23,
2021, with respect to the consolidated financial statements of Cimarex Energy Co., and the effectiveness of internal control over financial
reporting, incorporated herein by reference and to the reference to our firm under the heading &ldquo;Experts&rdquo; in the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">/s/ KPMG LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Denver, Colorado</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 4, 2021</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>4
<FILENAME>tm2129008d1_ex23-4.htm
<DESCRIPTION>EXHIBIT 23.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2in"><B>Exhibit
23.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Miller and Lents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Global Oil and Gas Consultants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October 4, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.75pt; background-color: white">We
hereby consent to the incorporation by reference in the Registration Statement on Form
S-3 of Coterra Energy Inc. to be filed with the Securities and Exchange Commission on or about October 4, 2021 (the
 &ldquo;Registration Statement&rdquo;) of all references to our firm and of our report dated January 27, 2021, included in or made a
part of the Annual Report on Form 10-K for the year ended December 31, 2020 of Coterra Energy Inc. We further consent to the use of
the name Miller and Lents, Ltd. under the heading &ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours very truly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MILLER AND LENTS, LTD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Texas Registered Engineering Firm No. F-1442</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 4%">By: </TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 46%">/s/ Jennifer A. Godbold</TD>
  <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jennifer A. Godbold, P.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vice President</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.5
<SEQUENCE>5
<FILENAME>tm2129008d1_ex23-5.htm
<DESCRIPTION>EXHIBIT 23.5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B><BR>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit
23.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>DEGOLYER AND MACNAUGHTON</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">5001 SPRING VALLEY ROAD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">SUITE 800 EAST</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">DALLAS, TEXAS 75244</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October&nbsp;4</FONT>,
2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the reference to DeGolyer and MacNaughton and to the incorporation by reference of our review of the proved oil, condensate,
natural gas liquids, and gas reserves, as of December&nbsp;31, 2020, estimated by Cimarex Energy Co. (&#8220;Cimarex&#8221;), that was
presented in our report of third party dated January&nbsp;20, 2021</FONT> as an exhibit in the Annual Report on Form&nbsp;10-K of Cimarex
for the fiscal year ended December&nbsp;31, 2020, in the form and context in which it appears or is incorporated by reference into the
Post-Effective Amendment No.&nbsp;1 on Form&nbsp;S-3 to the Registration Statement on Form&nbsp;S-4 of Coterra Energy Inc. to be filed
on or about October&nbsp;4, 2021 (the &#8220;Registration Statement&#8221;). We further consent to the use of the name DeGolyer and MacNaughton
under the heading &#8220;Experts&#8221; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ DeGOLYER and MacNAUGHTON</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DeGOLYER and MacNAUGHTON<BR>
Texas Registered Engineering Firm F-716</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>tm2129008d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="margin: 0"></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>PROSPECTUS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This document constitutes part of a prospectus
covering<BR>
securities that have been registered under the<BR>
Securities Act of 1933.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(A prospectus is a legal document that describes
the terms of a stock offering)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is May 15,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Description
of the<BR>
CIMAREX ENERGY CO.</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>2014
EQUITY INCENTIVE Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus covers 6,563,859 shares of common
stock, par value $0.01 per share, of Cimarex Energy Co., a Delaware corporation (&ldquo;Cimarex&rdquo;). These shares are issuable to
eligible employees, directors and other service providers pursuant to the terms of the Cimarex Energy Co. 2014 Equity Incentive Plan (&ldquo;Plan&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information regarding the Plan is governed by
the Plan document. In the event of conflict between this prospectus and the Plan document, the Plan document will control. In the event
of conflict between the Plan document and the agreement pursuant to which an award is granted under the Plan, the Plan document will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex established the Plan to allow eligible
employees and directors and other service providers to acquire shares of Cimarex common stock. This document and all references to &ldquo;you&rdquo;
and &ldquo;your&rdquo; apply only to eligible employees and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this prospectus will be updated
regularly by an appendix, a supplement, a new prospectus or by including information in the most recent annual report to stockholders
or the most recent proxy statement of the company. Any person referring to this prospectus after the lapse of a significant period of
time from the date of its initial publication should obtain and refer to all appendices and supplements. Any appendix or supplement received
after receipt of this prospectus should be kept with this prospectus and referred to whenever this prospectus is referred to.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities that may be offered by this prospectus or have determined
that this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>i</B></P>

</DIV>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table of Contents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 87%; font: 10pt Times New Roman, Times, Serif; text-align: left">Background Information</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">1</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Eligibility and Participation</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Options</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Stock Appreciation Rights</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Restricted Stock Awards and Restricted Stock Unit Awards</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Performance Awards</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Adjustments to Awards</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Federal Taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Plan Administration and General Plan Provisions</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ii</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Background Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex&rsquo;s Board of Directors approved and
adopted the Plan on February&nbsp;25, 2014, and the Plan was approved by Cimarex&rsquo;s stockholders at the annual meeting of shareholders
held on May&nbsp;15, 2014. The purpose of the Plan is to promote the interests of Cimarex by granting awards to certain employees, directors
and other service providers of Cimarex as an additional incentive for them to contribute to Cimarex&rsquo;s long-term financial success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan provides for grants of options, stock
appreciation rights, restricted stock, restricted stock units, performance shares, performance units, dividend equivalents and other stock-based
awards to eligible employees and directors and certain consultants and advisers who provide services to Cimarex. The Plan is administered
by the Compensation and Governance Committee of the Board of Directors (the &ldquo;Committee&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a stock option?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A stock option gives the option holder the opportunity
to buy a certain number of shares of Cimarex common stock (exercise the option) from Cimarex at a fixed price per share (the option price)
during a specific time period &ndash; no matter what the market price of the stock is when you exercise the option. The economic value
of a stock option is the appreciation, or increase, if any, in the value of the stock over the option price. You have the opportunity
to benefit from this increased value when you exercise your option. Stock options may be either non-qualified stock options or incentive
stock options (&ldquo;ISO&rdquo;). Different tax treatment applies to non-qualified stock options and ISOs (<I>See &ldquo;Income Tax Consequences
of Stock Options.&rdquo;) </I>Both ISOs and non-qualified stock options may be granted under the Plan; however,&nbsp;ISOs may be granted
only to employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a stock appreciation right?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A stock appreciation right gives you the opportunity
to receive payment from Cimarex when you exercise the stock appreciation right. The economic value of the stock appreciation right is
the appreciation, or increase, if any, in the value of the stock on the date of exercise over the grant price. Payment upon exercise may
be in cash, shares or any combination thereof, or in any other manner approved by the Committee. A stock appreciation right may be granted
in tandem with a stock option and, in that event, is exercisable during the period that its related stock option is exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a restricted stock award?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An award of &ldquo;restricted stock&rdquo; represents
shares of common stock and may be combined with a &ldquo;performance share&rdquo; as described below. The Committee determines the terms
and conditions, including vesting, applicable to restricted stock. The award is evidenced by an agreement approved by the Committee that
sets forth the terms and conditions of the restricted stock, and the number of shares subject to the award will be maintained in a book-entry
registration by Cimarex&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a restricted stock unit?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An award of a &ldquo;restricted stock unit&rdquo;
represents a right granted to you to receive a share of common stock or a payment equal to the value of a share of common stock on a determined
payment date. The restricted stock unit is evidenced by an agreement approved by the Committee that sets forth the terms and conditions
of the award, and the number of shares subject to the award will be maintained by Cimarex in a book-entry registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a performance share award?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An award of a &ldquo;performance share&rdquo;
is denominated in shares of restricted stock. The final number of shares to be retained by you is measured at the end of a performance
period based upon the achievement of performance goals established by the Committee at the time of grant. Cimarex will notify you at the
time of a grant of a performance share of the terms of the award, including the performance period and performance goals. The award is
evidenced by an agreement approved by the Committee that sets forth the terms and conditions of the award, and the number of shares subject
to the award will be maintained in a book-entry registration by Cimarex&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a performance unit?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An award of a &ldquo;performance unit&rdquo; is
recorded in the form of a bookkeeping entry representing a contingent right to receive a share of common stock or a payment equal to the
value of common stock. The final value of a performance unit to be paid to you is measured at the end of a performance period based upon
the achievement of performance goals established by the Committee at the time of grant. Cimarex will notify you at the time of a grant
of a performance unit of the terms of the award, including the performance period and performance goals. The award is evidenced by an
agreement approved by the Committee that sets forth the terms and conditions of the award, and the number of shares subject to the award
will be maintained by Cimarex in a bookkeeping entry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Eligibility and Participation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who is eligible to receive a grant under the
Plan?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employees and directors of Cimarex and its subsidiaries
and affiliates and certain consultants or advisers providing services to Cimarex and its subsidiaries and affiliates are eligible for
grants under the Plan when selected by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What if I transfer to a Cimarex subsidiary
or take a leave of absence?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you transfer to a subsidiary or affiliate of
Cimarex, or if you take an authorized leave of absence, you will not be treated as terminating employment under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Does the Plan have any of the same benefits
as a qualified retirement plan (including a 401(k) plan)?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan is not a qualified retirement plan and,
therefore, does not have the same tax deferral benefits, nor is the Plan subject to any provisions of the Employee Retirement Income Security
Act of 1974 (ERISA). Your participation in the Plan does not affect your ability to participate in Cimarex&rsquo;s 401(k)&nbsp;plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stock Options</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What does it mean when my option becomes &ldquo;exercisable&rdquo;?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When your option becomes exercisable (when the
option has vested), you can purchase shares of common stock from Cimarex at the option price established on the grant date, regardless
of the market price of the shares when you exercise your option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2</B></P>

</DIV>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When does my option become exercisable?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For your option to become exercisable, you must
have been an employee or director of Cimarex continuously throughout the vesting period beginning on the grant date and you must be an
employee or director on the vesting date. The Committee will determine the vesting period and the dates on which the options will become
exercisable at the time of grant and will state this information in your option award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For how long will my option remain exercisable?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once the option vests, you will be able to exercise
your option during the term of your option. Each option award agreement will set forth the extent, if any, to which you have the right
to exercise the vested portion of an option following termination of service. The Committee will determine the exact term of the option
at the time of grant and will state this information in your option award agreement. In the case of a non-qualified option, the Plan provides
for a term not longer than seven years. In the case of ISOs, options will not be exercisable more than five years from the date of grant
if, on the date of grant, you own more than 10% of Cimarex common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is the option price?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The option price is the price per share that
you will pay if you decide to exercise your option. The Committee will establish the option price per share of common stock on the date
the option is granted and this price will be equal to, or greater than, the fair market value of a share of common stock on the grant
date. In the case of ISOs, the option price will be at least 110% of the fair market value on the date of grant if, on the date of grant,
you own more than 10% of the Cimarex common stock. The &ldquo;fair market value&rdquo; generally will be determined as the closing price
reported for a share of Cimarex common stock on the day for which such value is to be determined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What must I do to exercise my option?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To exercise your option:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You must give notice to Cimarex (the Corporate Secretary) specifying the number of shares you intend to
purchase.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You must also pay Cimarex the total option price for the shares purchased, including any applicable taxes.
<I>(See, &ldquo;Federal Taxes&rdquo; for details.)</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>3</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How do I pay the total option price when I
exercise my option?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex provides various methods to pay the total
option price when you exercise your option:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You may pay with cash, or by check, bank draft or money order payable to the order of Cimarex.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You may deliver to Cimarex a number of shares of Cimarex common stock that have a fair market value equal
to the total option price subject to certain conditions. The fair market value is determined on the date you deliver the shares to Cimarex.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You may pay through a transaction involving a licensed broker or dealer (acceptable to Cimarex) acting
on your behalf to sell shares and deliver all or part of the sale proceeds to Cimarex in payment of the option price and applicable tax
withholding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You may pay the exercise price and required tax withholding with shares of Cimarex common stock withheld
pursuant to the exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">A combination of the foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Are there rules&nbsp;regarding the number of
shares I may purchase when I exercise my option?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you decide to exercise your option, you may
purchase some or all of the shares subject to the option that are vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When do I have rights as a stockholder on my
option shares?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither you nor anyone else will become the owner
of common stock subject to the option, or have any of the rights that a holder of such stock would have, until you have exercised your
option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When do I receive dividends on my option shares?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not receive or accrue dividends until
you exercise your option and purchase the stock. Once you exercise your option, you will receive dividends, to the extent declared on
the common stock, but only if you continue to own the shares and own them on the applicable dividend record date and only if the Cimarex
Board of Directors decides to pay a dividend. Cimarex currently pays quarterly dividends of $.16 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What happens if I terminate my employment or
service on the Board <I>before</I> I exercise my option?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When your option is granted, the Committee determines
whether you can exercise your option after you terminate employment or terminate your service on the Board of Directors. Such determination
will be reflected in your option agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Is my option transferable?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During your lifetime, only you can exercise your
option. In general, you cannot transfer options, except by will or the laws of descent and distribution. At Cimarex&rsquo;s discretion,
however, under certain circumstances you may be permitted to transfer an option (other than an ISO), together with your associated exercise
rights, to certain family members or to trusts for their benefit, or to partnerships in which family members are the only partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>4</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stock Appreciation Rights (&ldquo;SAR&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When does my SAR become exercisable?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For your SAR to become exercisable, you must have
been an employee or director of Cimarex continuously throughout the vesting period beginning on the grant date and you must be an employee
or director on the vesting date. The Committee will determine the vesting period and the dates on which the SAR will become exercisable
at the time of grant and will state this information in your award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For how long will my SAR remain exercisable?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once the SAR vests, you will be able to exercise
your SAR during the term of the SAR. Each SAR award agreement will set forth the extent, if any, to which you have the right to exercise
the vested portion of the SAR following termination of service. The Committee will determine the exact term of the SAR at the time of
grant and will state this information in your award agreement. The Plan provides for a maximum term of seven years from the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is the SAR price?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SAR price is the price per share that you
will pay if you decide to exercise your SAR. The Committee will establish the SAR price per share of common stock on the date the SAR
is granted and this price will be equal to, or greater than, the fair market value of a share of common stock on the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What does it mean when my SAR becomes &ldquo;exercisable&rdquo;?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When your SAR has vested, you can receive payment
from Cimarex by multiplying the excess of the Fair Market Value of a share on the date of exercise over the grant price by the number
of shares you elect to exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What must I do to exercise my SAR?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To exercise your SAR:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">You must give notice to Cimarex (the Corporate Secretary) specifying the number of SARs you intend to
exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Upon exercise, you will receive an amount (in cash or shares) determined by the excess of the fair market
value of a share of Cimarex stock on the date of exercise over the SAR price multiplied by the number of shares covered by your SAR exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What will I receive when I exercise my SAR?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the discretion of the Committee, the payment
upon exercise of your SAR may be in cash, shares of Cimarex common stock, or any combination thereof, or in any other manner approved
by the Committee. The form of the settlement will be stated in your award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Are there rules&nbsp;regarding the number of
SARs I may exercise?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you decide to exercise your SAR, you may exercise
some or all of the SARs subject to the your award that are vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>5</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When do I have rights as a stockholder on my
SARs?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither you nor anyone else will become the owner
of common stock subject to the SAR, or have any of the rights that a holder of such stock would have, until you have exercised your SAR
and been issued shares in settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When do I receive dividends on my SARs?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not receive or accrue dividends on your
SARs. Once you exercise your SAR and if you receive stock, you will receive dividends, to the extent declared on the common stock, but
only if you continue to own the shares and own them on the applicable dividend record date and only if the Cimarex Board of Directors
decides to pay a dividend. Cimarex currently pays quarterly dividends of $.16 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What happens if I terminate my employment or
service on the Board <I>before</I> I exercise my SAR?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When your SAR is granted, the Committee determines
whether you can exercise your SAR after you terminate employment or terminate your service on the Board of Directors. Such determination
will be reflected in your award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Is my SAR transferable?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During your lifetime, only you can exercise the
SAR. In general, you cannot transfer SARs or other awards, except by will or the laws of descent and distribution. At Cimarex&rsquo;s
discretion, however, under certain circumstances you may be permitted to transfer an SAR, together with your associated exercise rights,
to certain family members or to trusts for their benefit, or to partnerships in which family members are the only partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Restricted Stock and Restricted Stock Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When will restricted stock awards or restricted
stock unit awards be issued?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number and timing of restricted stock awards
or restricted stock unit awards is subject to the discretion of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Are there conditions to restricted stock awards
or restricted stock unit awards?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Generally, the vesting of each restricted
stock award or each restricted stock unit award will require the holder to remain employed by Cimarex (or a subsidiary or affiliated entity)
for a prescribed period. The Committee may impose additional vesting conditions on restricted stock awards, as it deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Will the vesting of restricted stock awards
or restricted stock unit awards accelerate?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The vesting of restricted stock awards and restricted
stock unit awards will accelerate upon a &ldquo;change in control&rdquo; as defined in the Plan or if the Committee, in its sole discretion,
determines to accelerate the vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Do any transfer restrictions apply to shares
of restricted stock?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of restricted stock may not be sold,
transferred, pledged, assigned or otherwise alienated or hypothecated until the end of the applicable restriction period established by
the Committee and specified in the award agreement. The Committee may impose such other restrictions as it deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>6</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Will a holder of restricted stock or a restricted
stock unit have rights as a stockholder?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holder of restricted stock will generally
have the rights of a stockholder to vote the shares of restricted stock, and the Committee may provide in the award agreement that the
holder of restricted stock will be entitled to cash dividends. The holder of restricted stock units will have no rights of a stockholder
with respect to the units. The Committee may provide in the award agreement that the holder of restricted stock units will receive dividend
equivalents, subject to the requirements of Section&nbsp;409A of the Internal Revenue Code. If any dividends or other distributions are
paid in shares of common stock, all such shares will be subject to the same restrictions on transferability as the shares of restricted
stock with respect to which they were paid. Even if the Committee grants you the right to receive dividends or dividend equivalents, you
will receive a dividend or dividend equivalent only if the Cimarex Board of Directors decides to pay a dividend and if you own the shares
or hold the units on the record date. Cimarex currently pays quarterly dividends of $.16 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Performance Shares and Performance Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What are performance awards?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Committee may in its discretion condition the grant, vesting or
payment of an award on the attainment of one or more pre-established objective performance goals and may grant performance shares and
performance units. A performance share or a performance unit entitles you to receive shares of Cimarex common stock, cash or a combination,
upon the attainment of performance goals and satisfaction of other terms and conditions determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who establishes the performance conditions
applicable to a performance award?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee establishes the applicable performance
period and the performance criteria to be used to establish performance goals which, when measured at the end of the performance period,
will determine the final value of the performance award to be paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When will performance shares or performance
units be issued?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number and timing of performance awards is
subject to the discretion of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Are there conditions to performance awards?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Generally, the vesting of each performance
share or performance unit will require the holder to remain employed by Cimarex (or a subsidiary or affiliated entity) for a prescribed
period. The Committee may impose additional vesting conditions as it deems appropriate. In addition, performance awards are subject to
performance conditions established by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Will the vesting of performance awards accelerate?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The vesting of performance awards will accelerate
only if the Committee, in its sole discretion, determines to accelerate the vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Do any transfer restrictions apply to performance
shares or performance units?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holder of a performance share or performance
unit may not sell, transfer, pledge, assign or otherwise alienate or hypothecate performance awards during the applicable restriction
period, other than by the laws of descent and distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>7</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Will a holder of a performance award have rights
as a stockholder?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holder of a performance share will generally
have the rights of a a stockholder to vote the performance shares. Holders of performance units do not have any rights of a stockholder.
Dividends will accrue on a performance share and will only be paid at the end of the vesting period and then only on the shares earned
based on the achievement of the performance goals. Even if the Committee grants you the right to receive dividends, you will accrue a
dividend only if the Cimarex Board of Directors decides to pay a dividend and if you own the shares on the record date. Cimarex currently
pays quarterly dividends of $.16 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Adjustments to Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What happens if there is a change in Cimarex&rsquo;s
stock, such as a stock split?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex will make appropriate adjustments to the
number and class of shares covered by options, SARs, restricted stock, restricted stock units, performance shares and performance units
granted under the Plan, as well as to the option and SAR price, to reflect changes in the outstanding Cimarex common stock (or other changes
in corporate capitalization), resulting from a stock dividend, stock split, reverse split, recapitalization, merger, consolidation, extraordinary
dividend or distribution payable in cash or property, combination or exchange of shares, separation, reorganization or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What happens if Cimarex is acquired by another
company, or otherwise experiences a change in control?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Cimarex is involved in a &ldquo;change in control,&rdquo;
all outstanding options, SARs, restricted stock and restricted stock units will immediately become fully vested. The performance period
for performance shares and performance units will end immediately before the change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Are there other adjustments Cimarex may make
if a &ldquo;change in control&rdquo; occurs?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At its discretion, if there is a &ldquo;change
in control,&rdquo; Cimarex may also make adjustments to the options, SARs and other awards granted under the Plan. Cimarex may also arrange
with the surviving entity for the surviving entity to assume outstanding Cimarex options, SARs or other awards, or to substitute options
or SARs to purchase common stock of the surviving entity for your Cimarex options, SARs or other awards covering the stock of the surviving
entity for your Cimarex stock awards. The new awards would have terms that are similar to the Cimarex awards that they replace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is a &ldquo;change in control&rdquo;?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A &ldquo;change in control&rdquo; means the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Subject to certain exceptions described in the Plan, the acquisition by any individual, entity or group
(within the meaning of Section&nbsp;13(d)(3)&nbsp;or 14(d)(2)&nbsp;of the Securities Exchange Act of 1934) of beneficial ownership of
30% or more of either:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
then outstanding shares of Cimarex common stock, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
combined voting power of the then outstanding Cimarex voting securities entitled to vote generally in the election of directors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>8</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provided
that the following acquisitions shall not constitute a &ldquo;change in control&rdquo;: (1)&nbsp;any acquisition directly from Cimarex,
(2)&nbsp;any acquisition by Cimarex, (3)&nbsp;any acquisition by any employee benefit plan sponsored or maintained by Cimarex or (4)&nbsp;any
acquisition by any corporation pursuant to a transaction described in section (iii)&nbsp;below; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Individuals who, as of May&nbsp;15, 2014, constitute the Cimarex Board cease for any reason to constitute
at least a majority of the Board; provided that any new director approved by a vote of at least a majority of such incumbent directors
shall not be treated as a new director for this purpose, except that any new director whose initial assumption of office occurs as a result
of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation
of proxies or consents by or on behalf of a person other than the Board shall be treated as a new director for this purpose; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">The closing of a reorganization, share exchange, or merger, unless, following such business combination:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
or substantially all of the individuals and entities who were the beneficial owners, respectively, of the outstanding common stock and
voting securities of Cimarex immediately prior to the business combination will beneficially own, directly or indirectly, more than 40%
of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such business combination
in substantially the same proportions as their ownership, immediately prior to such business combination, of the outstanding common stock
and voting securities of Cimarex, as the case may be; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
least a majority of the members of the Board of Directors of the corporation resulting from the business combination were members of the
Cimarex Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such business combination,
or were elected, appointed or nominated by the Board; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">The sale or other disposition of all or substantially all of the assets of Cimarex, other than to a corporation,
with respect to which following such sale or other disposition:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">A.</TD><TD STYLE="text-align: justify">more than 40% of, respectively, the then outstanding shares of common stock of such corporation and the
combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors
is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial
owners, respectively, of the outstanding common stock and outstanding voting securities of Cimarex immediately prior to such sale or other
disposition in substantially the same proportion as their ownership, immediately prior to such sale or other disposition, of the outstanding
common stock and outstanding voting securities of Cimarex, as the case may be; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">B</TD><TD STYLE="text-align: justify">at least a majority of the members of the board of directors of such corporation were members of the Cimarex
Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such sale or other disposition
of assets of Cimarex or were elected, appointed or nominated by the Board; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD STYLE="text-align: justify">The closing of a complete liquidation or dissolution of Cimarex.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>9</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Federal Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax consequences of awards granted under the
Plan are complex and depend, in large part, on the surrounding facts and circumstances. This section provides a brief summary of certain
significant federal tax consequences of the Plan, under existing U.S. law. This summary is not a complete statement of applicable law
and is based upon the Internal Revenue Code, as well as administrative and judicial interpretations of the Code, as in effect on the date
of this description. If federal tax laws, or interpretations of such laws, change in the future, the information provided here may no
longer be accurate. This section does not consider state, local, or foreign tax consequences. Nor does it discuss the effect of gift,
estate, or inheritance taxes &ndash; except with respect to transferred options. Therefore, it is important that you consult with your
tax advisor before taking any action with respect to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are my tax withholding obligations?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are an employee, you must pay in cash,
or make other arrangements satisfactory to Cimarex, any tax withholding obligations that arise under applicable law with respect to an
award granted under the Plan. Such taxes are payable when you first recognize the income associated with the option or SAR as taxable
income or when the restricted stock or stock unit is no longer subject to restrictions. Under certain circumstances, you may be permitted
to elect withholding of common stock otherwise deliverable to you or to tender pre-owned common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a non-employee director, you are not
subject to withholding; however, you must make quarterly payments of estimated tax with respect to income recognized from an award granted
under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Income Tax Consequences of Stock Options and
SARs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When am I taxed on my option or SAR?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You are not taxed on your option or SAR when it
is granted. However, you will generally be taxed when you exercise your option or SAR and purchase the common stock, except in the case
of ISOs. ISOs are generally not taxed until the stock acquired upon exercise of the ISO is ultimately sold. The difference between the
market value of the common stock at the time you exercise an ISO and the exercise price, however, is treated as an &ldquo;item of adjustment&rdquo;
for purposes of the Alternative Minimum Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How is the tax upon exercise of an option or
an SAR calculated?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon exercise of an option (other than an ISO)
or SAR, you will generally recognize ordinary income in an amount equal to the excess of the fair market value of the underlying stock
on the date you exercise your option or SAR over the total option or SAR price of that stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences if I sell my
purchased shares?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When you sell your shares of stock acquired upon
exercise of a non-qualified option or SAR, you generally will have a capital gain (or loss), depending on the difference between the sale
price and your basis in the shares. Your basis will generally be the amount of your exercise price plus the amount of compensation recognized
at exercise. The capital gain (or loss) is considered &ldquo;long term&rdquo; or &ldquo;short term,&rdquo; depending on how long you have
held such stock. When you sell shares of stock acquired upon exercise of an ISO, if you have held the stock for at least one year after
the date the shares were transferred to you and two years after the date of its grant, you generally will have a capital gain (or loss),
depending on the difference between the sale price and the exercise price of the option. If you sell stock acquired upon exercise of an
ISO without holding the stock for at least one year, a portion of your gain, if any, will be treated as ordinary compensation income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>10</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences of stock options
and SARs to Cimarex?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex generally will be entitled to a federal
tax deduction equal to the amount that you and other eligible employees or directors realize as compensation income upon the exercise
of the options or SARs. Cimarex is generally not entitled to a federal income tax deduction upon the exercise of an ISO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Income Tax Consequences of Restricted Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When am I taxed on my restricted stock?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, you are not taxed on restricted stock
when it is granted. You are taxed when the restrictions lapse and the stock is no longer subject to a substantial risk of forfeiture or
is transferable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can make an election under Section&nbsp;83(b)&nbsp;of
the Internal Revenue Code to be taxed when the restricted stock is granted. You must make the election within 30 days after the restricted
stock is transferred to you. Once you make the election, it is irrevocable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How is the tax calculated?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you do not make an 83(b)&nbsp;election, you
recognize ordinary income equal to the fair market value of the stock on the date the restrictions lapse minus the amount, if any, that
you paid for the restricted stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you make an 83(b)&nbsp;election, you recognize
ordinary income equal to the fair market value of the stock on the date the restricted stock is granted minus the amount, if any, that
you paid for the restricted stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences of dividends
on restricted stock?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you do not make an 83(b)&nbsp;election and
you receive a dividend on shares of restricted stock, the dividend is taxed to you as compensation income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you make an 83(b)&nbsp;election and you receive
a dividend on shares of restricted stock, the dividend is taxed to you as dividend income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What happens if I forfeit the restricted stock?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not have any income with respect to the
forfeited shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences if I sell my
shares after the restrictions lapse?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When you sell your shares of stock, you generally
will have a capital gain (or loss), depending on the difference between the sale price and the fair market value of the stock on the date
the restrictions lapsed (or if you made an 83(b)&nbsp;election, the date the restricted stock was granted). The capital gain (or loss)
is considered &ldquo;long term&rdquo; or &ldquo;short term,&rdquo; depending on how long you have held such stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences of restricted
stock to Cimarex?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex generally will be entitled to a federal
income tax deduction equal to the amount that you and other eligible employees or directors realize as compensation income when the restrictions
lapse or, if you make an 83(b)&nbsp;election, when the restricted stock is granted, assuming that the compensation satisfies the ordinary
and necessary and reasonable compensation requirements for deductibility and that the deduction is not limited by Section&nbsp;162(m)&nbsp;of
the Internal Revenue Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>11</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Income Tax Consequences of Performance Shares</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Restricted Stock Units and Performance Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>When am I taxed on my performance shares, restricted
stock units and performance units?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, you are not subject to income tax when
performance shares, restricted stock units or performance units are granted. Upon the settlement of such an award, you will recognize
ordinary income in the year of receipt in an amount equal to any cash received and the fair market value of the vested shares received.
If you receive shares of restricted stock, you will be taxed in the same manner as described above under &ldquo;Income Tax Consequences
of Restricted Stock.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences of dividends
on performance shares, restricted stock units and performance units?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee may grant you the right to receive
dividend equivalents on performance shares, restricted stock units or performance units. Any dividend equivalents received on performance
shares or performance units will be accrued during the performance period and only paid at the time of vesting and only with respect to
the shares that are issued upon attainment of the performance goals. You do not pay any tax on accrued but unpaid dividends. If the Committee
grants you the right to receive dividend equivalents during the restricted period on shares represented by restricted stock units, the
dividend is taxed to you as compensation income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How is the tax calculated?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the performance shares, restricted stock
units or performance units become payable, you will have taxable compensation income equal to (1)&nbsp;if paid in cash, the amount of
cash received or (2)&nbsp;if paid in shares of common stock, the fair market value of the common stock at the time of payment. Upon the
sale of any shares received, any gain or loss, based on the difference between the sale price and the fair market value on payment of
the shares in common stock, will be taxed as capital gain or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What happens if I forfeit the performance shares,
the restricted stock units or the performance units?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not have any income with respect to the
forfeited shares or stock units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are the tax consequences of performance
shares, restricted stock units or performance units to Cimarex?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex generally will be entitled to a federal
income tax deduction equal to the amount that you and other eligible employees or directors realize as compensation income when the stock
or the stock units and dividend equivalents, if any, are paid, assuming that the compensation satisfies the ordinary and necessary and
reasonable compensation requirements for deductibility and that the deduction is not limited by Section&nbsp;162(m)&nbsp;of the Internal
Revenue Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>12</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certain Parachute Payment Considerations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under certain circumstances, accelerated vesting
or exercise of options or accelerated vesting of restricted stock, restricted stock units, performance stock or performance stock units
in connection with a &ldquo;change in control&rdquo; of Cimarex might be considered a &ldquo;parachute payment&rdquo; for purposes of
the golden parachute payment provisions of Section&nbsp;280G of the Internal Revenue Code. In that event, you may be subject to an excise
tax equal to 20% of the amount of the excess parachute payment, and Cimarex may be denied a tax deduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Section 409A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Awards granted under the Plan may have features that could cause them
to be treated as &ldquo;nonqualified deferred compensation&rdquo; under Section&nbsp;409A of the Internal Revenue Code (&ldquo;Section&nbsp;409A&rdquo;),
which imposes significant penalties for noncompliance. Specifically, if an arrangement does not comply with Section&nbsp;409A, any deferred
amount will be taxed upon vesting (even if it is payable at a later time) and, in addition, you will be subject to an additional tax equal
to 20% of the taxable amount plus an interest penalty. Stock options and SARs are generally not subject to Section&nbsp;409A if their
exercise price is at least equal to the fair market value of the common stock on the grant date. Stock units will generally be in compliance
with Section&nbsp;409A if the unit agreements provide only for payment at a time permitted by Section&nbsp;409A (for example, on a specified
and fixed payment date or dates, at separation from service, at death, upon a change in control that meets certain requirements). Restricted
stock is not subject to Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Plan Administration and General Plan Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who administers the Plan?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee (or another committee of members
of the Board of Directors) administers the Plan. The Committee has broad authority to administer and interpret the Plan, including the
authority to determine who is eligible to receive a grant under the Plan and to determine the specific provisions of the grant. The terms
of options, SARs, restricted stock, restricted stock units, performance shares and performance units received under the Plan may differ
from grant to grant and from individual to individual. The Committee also has the authority to make or change any rules&nbsp;for the administration
of the Plan and to accelerate the exercisability of an outstanding option or share of restricted stock. All decisions and actions of the
Committee are final. The Committee may delegate certain of its responsibilities and authority under the Plan to an officer or officers
of Cimarex who are also directors, including the right to grant awards, but the right to grant awards to eligible employees or directors
who are subject to SEC Rule&nbsp;16b-3 may not be delegated by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each award under the Plan will be evidenced by
an award agreement. The Committee has the authority to prescribe the form and, subject to the terms of the Plan, to determine the content
of all award agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How many shares of common stock are reserved
for grants and awards under the plan?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A total of__________&nbsp;shares of Cimarex&rsquo;s
common stock are reserved for issuance under the Plan. A grant of one share of restricted stock, restricted stock unit, performance share
or performance unit will reduce the Plan shares by 2.38 shares and a grant of one share pursuant to an option or an SAR grant will reduce
the Plan shares by one share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of Cimarex common stock may be either
authorized and unissued shares or previously issued shares acquired by Cimarex. If any stock award expires or terminates without having
been exercised in full, shares are forfeited because of the failure to meet a contingency or condition required for vesting, then the
shares not issued or forfeited will again become available for grant under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>13</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Are the shares restricted?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Issuance of the shares under the Plan will be
registered with the U.S. Securities and Exchange Commission. Consequently, upon becoming vested, they can be sold or transferred. However,
shares received by &ldquo;affiliates&rdquo; of Cimarex (as defined under Rule&nbsp;405 under the Securities Act of 1933), will be &ldquo;control
securities,&rdquo; and will be subject to restrictions on resale set forth in Rule&nbsp;144 under the Securities Act of 1933. Any certificate
representing such shares may bear a legend indicating that the transfer of such shares is restricted. However, affiliates can resell shares
acquired under the Plan pursuant to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the applicable provisions of Rule&nbsp;144,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any other applicable exemption from the registration requirements of the Securities Act of 1933, or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>a registration statement with respect to such shares under the Securities Act of 1933.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Securities Act of 1933, an affiliate
may not rely on this prospectus in connection with any reoffer or resale of shares of common stock acquired under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, &ldquo;affiliates&rdquo; are certain
senior officers, directors, or large shareholders of Cimarex.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If I am aware of important non-public information,
can I sell my stock before this news is disclosed to the public? For example, if I know Cimarex is having significant problems or that
Cimarex is about to acquire a competitor, can I sell my stock before Cimarex puts out a press release?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No.&nbsp; If you are aware of important inside
information, you must not sell shares of Cimarex stock, whether received upon exercise of an option or otherwise, before dissemination
of the information to the public. Basically, &ldquo;inside information&rdquo; is information that is both important (material) and non-public
(not disclosed through press releases, newspaper articles or otherwise to the public that buys and sells securities). Whether information
is material will depend on the specific circumstances. A general test is whether dissemination of the information to the public would
likely affect the market price of Cimarex&rsquo;s stock or would likely be considered important by people who are considering whether
to buy or sell Cimarex stock. If the information makes you want to buy or sell, it would probably have the same effect on others. Material
information may include projections, estimates or proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are contemplating selling your stock and
if you think you might have &ldquo;inside information,&rdquo; you must discuss your possible sale with Cimarex&rsquo;s General Counsel
or Chief Financial Officer. If, after this discussion, it is determined that the information is in fact inside information, you must wait
to sell your stock until after the information has been made available to the public. You must always abide by Cimarex&rsquo;s 2014 Insider
Trading Policy evidenced by the Memorandum to directors, officers and employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How long will the Plan remain effective?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan will terminate at the close of business
on May&nbsp;15, 2024, ten years after the effective date of the Plan. The Board of Directors may also terminate the Plan prior to the
termination date. You cannot be granted an award under the Plan after the Plan has terminated. However, awards granted prior to termination
may extend beyond the termination date for the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>14</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding: 10pt 10pt 5pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Can the Plan be amended or terminated before
the termination date?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex&rsquo;s Board of Directors has the right
to amend, alter, suspend, or terminate the Plan. However, the Board of Directors may not generally amend or terminate the Plan or any
outstanding awards in a manner that would impair your rights without your written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How can I get more information about Cimarex
common stock?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cimarex&rsquo;s common stock is traded on the
New York Stock Exchange under the ticker symbol &ldquo;XEC.&rdquo; You can find daily stock information in the New York Stock Exchange
composite listings in the newspapers. You can get additional information about Cimarex&rsquo;s common stock from any broker.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What else should I know?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus summarizes the provisions of the
Plan. Because this is a summary, it does not contain all the information that may be important to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional information about the Plan and its
administrators may be obtained from Cimarex at 1700 Lincoln Street, Suite&nbsp;1800, Denver, Colorado 80203, Attention: Corporate Secretary;
telephone number (303)&nbsp;295-3995.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may obtain, without charge, a copy of any
of the documents listed below, which are incorporated by reference in this prospectus, upon request to the Secretary at the address provided
above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Cimarex&rsquo;s latest annual report on Form&nbsp;10-K for the year ended December&nbsp;31, 2013 filed
on February&nbsp;26, 2014.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Cimarex&rsquo;s registration statement on Form&nbsp;10-12(b), including the description of Cimarex&rsquo;s
common stock, filed September&nbsp;3, 2002, including any amendment or report filed for the purpose of updating such registration statement
or description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">All other reports filed pursuant to Sections 13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of
1934 since the end of the fiscal year covered by the annual report referred to above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, all documents filed by Cimarex pursuant
to Sections&nbsp;13(a), 13(c), 14 and 15(d)&nbsp;of the Securities Exchange Act of 1934 after the date of this prospectus, and before
the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all such
securities then remaining unsold, shall be deemed to be incorporated by reference in this prospectus and to be a part hereof from the
date such documents are filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained herein or in a document,
all or a portion of which is incorporated or deemed to be incorporated by reference in this prospectus, shall be deemed to be modified
or superseded for purposes of this prospectus to the extent that a statement contained herein or in any subsequently filed document that
is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>15</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>tm2129008d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>SUMMARY OF CIMAREX ENERGY CO. AMENDED
AND RESTATED 2019 EQUITY INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a summary of the Cimarex Energy Co. Amended and Restated
2019 Equity Incentive Plan (the &ldquo;Amended 2019 Plan&rdquo;), an omnibus equity incentive plan that amended our existing 2019 Equity
Incentive Plan (the &ldquo;2019 Plan&rdquo;). The Amended 2019 Plan was approved by the Board of Directors of Cimarex on February&nbsp;17,
2021 and by the shareholders of Cimarex on May&nbsp;12, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The key features of the Amended 2019 Plan include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>A
                                            reserve of 6,900,000 new shares of our common stock that may be issued pursuant to awards
                                            under the Amended 2019 Plan. In addition, shares available for issuance under the 2019 Plan
                                            were transferred over to and made available for issuance under the Amended 2019 Plan, as
                                            will shares that become available as a result of forfeitures of awards made under the 2014
                                            Plan and 2019 Plan. As a result, as of May&nbsp;12, 2021, a total of 8,720,723 shares were
                                            available under the Amended 2019 Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>Fungible
                                            share design pursuant to which awards other than options and stock appreciation rights are
                                            counted against the share reserve at a rate of 2.38 shares per every share delivered under
                                            a full value award, and shares delivered pursuant to options and stock appreciation rights
                                            are counted against the share reserve on a 1:1 basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>A
                                            term that expires on February&nbsp;17, 2031;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>Permitted
                                            awards include, but are not limited to, options, stock appreciation rights (sometimes referred
                                            to as &ldquo;SARs&rdquo;), restricted stock, restricted stock units (sometimes referred to
                                            as &ldquo;RSUs&rdquo;), performance stock units (sometimes referred to as &ldquo;PSUs&rdquo;),
                                            and other cash and stock-based awards;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>No
                                            direct or indirect repricing of options or stock appreciation rights without shareholder
                                            approval;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>Stringent
                                            share recycling provisions that prohibit recycling of shares used as consideration for tax
                                            withholding or as consideration for option exercises, along with full counting of all shares
                                            subject to stock-settled stock appreciation rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>A
                                            minimum one-year vesting schedule on all awards types under the Amended 2019 Plan (applicable
                                            to at least 95% of the shares authorized for issuance so that up to 5% of the authorized
                                            shares may be issued pursuant to exceptions to the minimum one-year vesting); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>Dividends
                                            and dividend equivalents on performance-based awards are accrued and paid only if related
                                            awards become vested; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>No
                                            excise tax gross ups on equity awards.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Description of the Amended 2019 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following summary of material terms of the Amended 2019 Plan does
not purport to be complete and is subject to and qualified in its entirety by the actual terms of the Amended 2019 Plan. A copy of the
Amended 2019 Plan is provided as Appendix A to this summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Purpose
                                            of the Amended 2019 Plan</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The purpose of the Amended 2019 Plan is to promote the success of
the Company and the interests of its shareholders by providing an additional means for the Company to attract, motivate, retain and reward
directors, officers, employees and other eligible persons (including certain consultants and advisors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board or one or more committees consisting of directors appointed
by the Board will administer the Amended 2019 Plan. The Board intends to delegate general administrative authority for the Amended 2019
Plan to the Compensation Committee, which is comprised of directors who qualify as independent under the rules&nbsp;promulgated by the
SEC and NYSE. Except where prohibited by applicable law, a committee may delegate some or all of its authority with respect to the Amended
2019 Plan to another committee of directors or to one or more officers of the Company. For purposes of Rule&nbsp;16b-3 of the Exchange
Act, the rules&nbsp;of the NYSE and for grants to non-employee directors, the Amended 2019 Plan must be administered by a committee consisting
solely of two or more independent directors. The appropriate acting body, be it the Board, a committee within its delegated authority,
or an officer within his or her delegated authority, is referred to in this section as the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Administrator has broad authority under the Amended 2019 Plan
with respect to award grants including, without limitation, the authority:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>To
                                            select participants and determine the type(s)&nbsp;of award(s)&nbsp;that they are to receive;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>To
                                            determine the number of shares that are to be subject to awards and the terms and conditions
                                            of awards, including the price (if any) to be paid for the shares or the award;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>To
                                            cancel, modify, or waive the Company&rsquo;s rights with respect to, or modify, discontinue,
                                            suspend, or terminate any or all outstanding awards, subject to any required consents, and
                                            subject to the repricing prohibition described below;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>To
                                            accelerate or extend the vesting or exercisability or extend the term of any or all outstanding
                                            awards subject to any required consents;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>Subject
                                            to the other provisions of the Amended 2019 Plan, to make certain adjustments to outstanding
                                            awards and authorize the conversion, succession or substitution of awards; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD>To
                                            allow the purchase price of awards or shares of the Company&rsquo;s common stock to be paid
                                            in the form of cash, check, or electronic funds transfer, by the delivery of already-owned
                                            shares of the Company&rsquo;s common stock or by a reduction of the number of shares deliverable
                                            pursuant to the awards, by services rendered by the recipient of the awards, by notice of
                                            third party payment or by cashless exercise, on such terms as the Administrator may authorize,
                                            or any other form permitted by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Eligibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Persons eligible to receive awards under the Amended 2019 Plan include
officers and employees of the Company or any of its subsidiaries, non-employee directors of the Company, and certain individual consultants
who render bona fide services to the Company or any of its subsidiaries (other than services in connection with the offering or sale
of securities or as a market maker or promoter of securities of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Authorized Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number shares of Company common stock authorized for issuance
pursuant to awards under the Amended 2019 Plan is 8,720,723, which is equal to the sum of (i)&nbsp;6,900,000 shares of Company
common stock, plus (ii)&nbsp;the shares of Company common stock available for issuance under the 2019 Plan upon approval of the
Amended 2019 Plan on May&nbsp;12, 2021, plus (iii)&nbsp;any shares that would have otherwise become available for issuance under the
2019 Plan as a result of forfeitures of outstanding awards made under the 2019 Plan and 2014 Plan. The Amended 2019 Plan generally
provides that shares issued in connection with awards that are granted by or become obligations of the Company through the
assumption of awards (or in substitution for awards) in connection with an acquisition of another company will not count against the
shares available for issuance under the Amended 2019 Plan, except as may be required by the Administrator or applicable law or stock
exchange rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Amended 2019 Plan uses a fungible share design, pursuant to which
shares delivered pursuant to options and stock appreciation rights count against the share reserve on a 1:1 basis, and shares delivered
pursuant to all other awards count against the share reserve at a rate of 2.38 shares per share delivered under the award. Shares that
are subject to or underlie awards that expire or for any reason are canceled or terminated, are forfeited, fail to vest, or for any other
reason are not paid or delivered under the Amended 2019 Plan are available for reissuance under the Amended 2019 Plan at the same rate
as they would have been taken into account under the fungible share counting system described above. However, the Amended 2019 Plan prohibits
liberal share recycling. Accordingly, shares tendered or withheld to satisfy the exercise price of options or tax withholding obligations,
and shares covering the portion of exercised stock-settled SARs (regardless of the number of shares actually delivered), count against
the share limit in accordance with the fungible share counting system described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Awards Under the Amended 2019 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because awards under the Amended 2019 Plan are granted in the discretion
of the Board or a committee of the Board, the type, number, recipients and other terms of future awards cannot be determined at this
time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>No Repricing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In no event will any adjustment be made to a stock option or stock
appreciation right award under the Amended 2019 Plan (by amendment, cancellation and regrant, exchange for other awards or cash or other
means) that would constitute a repricing of the per share exercise or base price of the award, unless such adjustment is approved by
the shareholders of the Company. Adjustment made in accordance with the Amended 2019 Plan to reflect a stock split or similar event are
not deemed to be a repricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Minimum Vesting Schedule</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Amended 2019 Plan requires a minimum one-year cliff vesting schedule
for all equity award types under the Amended 2019 Plan. This minimum vesting schedule will apply to at least 95% of the shares authorized
for grant under the Amended 2019 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Dividends and Dividend Equivalents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accrued dividends or dividend equivalent amounts shall not be paid
on performance-based awards unless and until the awards to which they relate become vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Types of Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Amended 2019 Plan authorizes stock options, SARs, restricted stock,
RSUs, PSUs and other forms of awards that may be granted or denominated in or otherwise determined by reference to the Company&rsquo;s
common stock, as well as cash awards. The Amended 2019 Plan provides flexibility to offer competitive incentives and to tailor benefits
to specific needs and circumstances. Awards may, in certain cases, be paid or settled in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Stock
                                            Options</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A stock option is a right to purchase shares of the Company&rsquo;s
common stock at a future date at a specified price per share (the &ldquo;exercise price&rdquo;). The per share exercise price of an option
generally may not be less than the fair market value of a share of the Company&rsquo;s common stock on the date of grant. The maximum
term of an option is seven years from the date of grant. An option may be either an incentive stock option or a nonqualified stock option.
Incentive stock options are taxed differently than nonqualified stock options and are subject to more restrictive terms under the Internal
Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;) and the Amended 2019 Plan. Incentive stock options may be granted only to employees
of the Company or a subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Stock
                                            Appreciation Rights</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A stock appreciation right is the right to receive payment in cash
and/or common stock of an amount equal to the excess of the fair market value of shares of the Company&rsquo;s common stock on the date
of exercise of the stock appreciation right over the base price of the stock appreciation right. The base price is established by the
Administrator at the time of grant of the stock appreciation right and cannot be less than the fair market value of a share of the Company&rsquo;s
common stock on the date of grant. Stock appreciation rights may be granted in connection with other awards or independently. The maximum
term of a stock appreciation right is seven years from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Restricted
                                            Stock</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares of restricted stock are shares of the Company&rsquo;s common
stock that are subject to forfeiture and to certain restrictions on sale, pledge, or other transfer by the recipient during a particular
period of employment or service or until certain performance vesting conditions are satisfied (the &ldquo;restricted period&rdquo;).
Subject to the restrictions provided in the applicable award agreement and the Amended 2019 Plan, a participant receiving restricted
stock, and/or the fair market value of all or a portion of the restricted stock in cash, may have all of the rights of a shareholder
as to such shares, including the right to vote and the right to receive dividends; provided, however, that dividends on shares subject
to performance-based vesting shall be accrued and shall be paid only if the restricted stock to which they relate become vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Restricted
                                            Stock Units</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A restricted stock unit represents the right to receive one share
of the Company&rsquo;s common stock, or the fair market value of one share of common stock in cash, on a specific future vesting or payment
date. Subject to the restrictions provided in the applicable award agreement and the Amended 2019 Plan, a participant receiving RSUs
has no rights as a shareholder with respect to the RSUs until the shares of common stock are issued to the participant. RSUs may be granted
with dividend equivalent rights. RSUs may be settled in cash if so provided in the applicable award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Performance
                                            Stock Units</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A performance stock unit (&ldquo;PSU&rdquo;) is a performance-based
award that entitles the recipient to receive shares of the Company&rsquo;s common stock, or the fair market value of some or all those
shares in cash, based on attainment of one or more performance goals. Each PSU shall designate a target number of shares payable under
the award, with the actual number of shares earned (if any) based on a formula set forth in the award agreement related to the attainment
of one or more performance goals. Subject to the restrictions provided in the applicable award agreement and the Amended 2019 Plan, a
participant receiving PSUs has no rights as a shareholder until the shares of common stock are issued to the participant. PSUs may be
granted with dividend equivalent rights that are payable only if the underlying PSUs are earned. PSUs may be settled in cash if so provided
in the applicable award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Cash Awards</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Administrator, in its sole discretion, may grant cash awards,
including without limitation discretionary awards, awards based on objective or subjective performance criteria, and awards subject to
other vesting criteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Other
                                            Awards</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The other types of awards that may be granted under the Amended 2019
Plan include, without limitation, stock bonuses, and similar rights to purchase or acquire shares of the Company&rsquo;s common stock,
and similar securities with a value derived from the value of or related to the Company&rsquo;s common stock or returns thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Change of Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event of a change of control (as defined in the Amended 2019
Plan), time-based awards shall become fully vested, and performance-based awards shall vest based on performance through the date of
the change of control (with the Administrator making any adjustments necessary to accommodate the truncated performance period of such
awards). In addition, the Administrator shall have full discretion to take whatever additional actions (not inconsistent with the accelerated
vesting described above) it deems necessary or appropriate, including but not limited to the following actions: (1)&nbsp;provide for
the assumption of such awards (or portions thereof) or the substitution of such awards (or portions thereof) with similar awards of the
surviving or acquiring Company; (2)&nbsp;provide for the termination of outstanding awards; (3)&nbsp;provide for the cash-out and cancellation
of any award (or portion thereof); and (4)&nbsp;take any other actions as the Administrator deems necessary or advisable in connection
with such change of control transaction. The Administrator may take different actions with respect to different participants under the
Amended 2019 Plan, different awards under the Amended 2019 Plan, and different portions of awards granted under the Amended 2019 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Transferability of Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Awards under the Amended 2019 Plan generally are not transferable
by the recipient other than by will or the laws of descent and distribution, or pursuant to domestic relations orders, and with respect
to awards with exercise features, are generally exercisable during the recipient&rsquo;s lifetime only by the recipient. Any amounts
payable or shares issuable pursuant to an award generally will be paid only to the recipient or the recipient&rsquo;s beneficiary or
representative. The Administrator has discretion, however, to establish written conditions and procedures for the transfer of awards
to other persons or entities, as long as such transfers comply with applicable federal and state securities laws and provided that any
such transfers are not for consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Adjustments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As is customary in plans of this nature, the share limits and the
number and kind of shares available under the Amended 2019 Plan and any outstanding awards, as well as the exercise or purchase prices
of awards, are subject to adjustment in the event of certain reorganizations, mergers, combinations, recapitalizations, stock splits,
stock dividends, or other similar events that change the number or kind of shares outstanding, and extraordinary dividends or distributions
of property to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>No Limit on Other Authority</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Amended 2019 Plan does not limit the authority of the Board or
any committee to grant awards or authorize any other compensation, with or without reference to the Company&rsquo;s common stock, under
any other plan or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Non-Competition and Clawback Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By accepting awards and as a condition to the exercise of awards and
the enjoyment of any benefits of the Amended 2019 Plan, participants agree to be bound by any clawback policy adopted by the Company
from time to time. Participants may also be subject to restrictive covenants if so required by the Administrator in any award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Awards to Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Amended 2019 Plan is the exclusive vehicle for awards of cash
and equity compensation to be paid or provided to the Company&rsquo;s non-employee directors. Cash awards to non-employee directors may
take any form determined by the Administrator in its sole and absolute discretion, including, but not limited to, retainers, committee
fees, chairperson fees, per meeting fees, and special fees for committee service. Cash awards paid to any non-employee director may not
exceed $400,000 in any fiscal year. Equity awards to non-employee directors may take any form determined by the Administrator in its
sole and absolute discretion (other than incentive stock options). Equity awards granted to any non-employee director may not have a
grant date fair value in excess of $400,000 in any fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Termination of, or Changes to, the
Amended 2019 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Administrator may amend or terminate the Amended 2019 Plan at
any time and in any manner. Shareholder approval for an amendment will be required only to the extent then required by applicable law
or any applicable stock exchange rules&nbsp;or as required to preserve the intended tax consequences of the Amended 2019 Plan. For example,
shareholder approval is required for any proposed amendment to increase the maximum number of shares that may be delivered with respect
to awards granted under the Amended 2019 Plan. Adjustments as a result of stock splits or similar events will not, however, be considered
amendments requiring shareholder approval. Unless terminated earlier by the Board, the authority to grant new awards under the Amended
2019 Plan will terminate ten years after the date on which the Amended 2019 Plan was approved by the Board. Outstanding awards generally
will continue following the expiration or termination of the Amended 2019 Plan. Generally speaking, outstanding awards may be amended
by the Administrator (except for a repricing), but the consent of the award holder is required if the amendment (or any plan amendment)
materially and adversely affects the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Certain Federal Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following summary of the federal income tax consequences of awards
under the Amended 2019 Plan is based upon federal income tax laws in effect on March&nbsp;26, 2021. This summary does not purport to
be complete, and does not discuss state, local or non-U.S. tax consequences. The tax consequences of individual awards may vary depending
upon the particular circumstances applicable to any individual participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Nonqualified
                                            Stock Options</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The grant of a nonqualified stock option under the Amended 2019 Plan
will not result in any federal income tax consequences to the participant or to the Company. Upon exercise of a nonqualified stock option,
the participant will recognize ordinary compensation income equal to the excess of the fair market value of the shares of common stock
at the time of exercise over the option exercise price. If the participant is an employee, this income is subject to withholding for
federal income and employment tax purposes. The Company is entitled to an income tax deduction in the amount of the income recognized
by the participant, subject to possible limitations imposed by the Code, including Section&nbsp;162(m)&nbsp;thereof. Any gain or loss
on the participant&rsquo;s subsequent disposition of the shares will be treated as long-term or short-term capital gain or loss, depending
on the sales proceeds received and whether the shares are held for more than one year following exercise. The Company does not receive
a tax deduction for any subsequent capital gain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Incentive
                                            Stock Options</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The grant of an incentive stock option (or &ldquo;ISO&rdquo;) under
the Amended 2019 Plan will not result in any federal income tax consequences to the participant or to the Company. A participant recognizes
no federal taxable income upon exercising an ISO (subject to the alternative minimum tax rules&nbsp;discussed below), and the Company
receives no deduction at the time of exercise. In the event of a disposition of stock acquired upon exercise of an ISO, the tax consequences
depend upon how long the participant has held the shares. If the participant does not dispose of the shares within two years after the
ISO was granted, nor within one year after the ISO was exercised, the participant will recognize a long-term capital gain (or loss) equal
to the difference between the sale price of the shares and the exercise price. The Company is not entitled to any deduction under these
circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the participant fails to satisfy either of the foregoing holding
periods (referred to as a &ldquo;disqualifying disposition&rdquo;), he or she will recognize ordinary compensation income in the year
of the disposition. The amount of ordinary compensation income generally is the lesser of (i)&nbsp;the difference between the amount
realized on the disposition and the exercise price or (ii)&nbsp;the difference between the fair market value of the stock at the time
of exercise and the exercise price. Such amount is not subject to withholding for federal income and employment tax purposes, even if
the participant is an employee of the Company. Any gain in excess of the amount taxed as ordinary income will generally be treated as
a short-term capital gain. The Company, in the year of the disqualifying disposition, is entitled to a deduction equal to the amount
of ordinary compensation income recognized by the participant, subject to possible limitations imposed by the Code, including Section&nbsp;162(m)&nbsp;thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The &ldquo;spread&rdquo; under an ISO (i.e., the difference between
the fair market value of the shares at exercise and the exercise price) is classified as an item of adjustment in the year of exercise
for purposes of the alternative minimum tax. If a participant&rsquo;s alternative minimum tax liability exceeds such participant&rsquo;s
regular income tax liability, the participant will owe the alternative minimum tax liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Restricted
                                            Stock</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restricted stock is generally taxable to the participant as ordinary
compensation income on the date that the restrictions lapse (i.e. the date that the stock vests), in an amount equal to the excess of
the fair market value of the shares on such date over the amount paid for such stock (if any). If the participant is an employee, this
income is subject to withholding for federal income and employment tax purposes. The Company is entitled to an income tax deduction in
the amount of the ordinary income recognized by the participant, subject to possible limitations imposed by the Code, including Section&nbsp;162(m)&nbsp;thereof.
Any gain or loss on the participant&rsquo;s subsequent disposition of the shares will be treated as long-term or short-term capital gain
or loss depending on the sales price and how long the stock has been held since the restrictions lapsed. The Company does not receive
a tax deduction for any subsequent gain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Participants receiving restricted stock awards may make an election
under Section&nbsp;83(b)&nbsp;of the Code (a &ldquo;Section&nbsp;83(b)&nbsp;Election&rdquo;) to recognize as ordinary compensation income
in the year that such restricted stock is granted in an amount equal to the excess of the fair market value on the date of the issuance
of the stock over the amount paid for such stock. If the participant is an employee, this income is subject to withholding for federal
income and employment tax purposes. If such an election is made, the recipient recognizes no further amounts of compensation income upon
the lapse of any restrictions and any gain or loss on subsequent disposition will be long-term or short-term capital gain or loss to
the recipient. However, if the stock is later forfeited, the participant will not be able to recover the tax previously paid pursuant
to the Section&nbsp;83(b)&nbsp;Election. The Section&nbsp;83(b)&nbsp;Election must be made within 30 days from the time the restricted
stock is issued. The Company is entitled to a deduction equal to the amount of income taken into account as a result of the Section&nbsp;83(b)&nbsp;Election,
subject to possible limitations imposed by the Code, including Section&nbsp;162(m)&nbsp;thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent dividends are paid while the restrictions on the stock
are in effect, any such dividends will be taxable to the participant as ordinary income (and will be treated as additional wages for
federal income and employment tax withholding purposes, if the recipient is an employee) and will be deductible by the Company (subject
to possible limitations imposed by the Code, including Section&nbsp;162(m)&nbsp;thereof), unless the participant has made a Section&nbsp;83(b)&nbsp;Election,
in which case the dividends will generally be taxed at dividend rates and will not be deductible by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Other
                                            Awards</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other awards (such as RSUs and PSUs) are generally treated as ordinary
compensation income as and when common stock or cash are paid to the participant upon vesting or settlement of such awards. If the participant
is an employee, this income is subject to withholding for income and employment tax purposes. The Company is generally entitled to an
income tax deduction equal to the amount of ordinary income recognized by the recipient, subject to possible limitations imposed by the
Code, including Section&nbsp;162(m)&nbsp;thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Section&nbsp;409A of the Internal
Revenue Code</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section&nbsp;409A of the Code provides certain requirements for the
deferral and payment of deferred compensation arrangements. In the event that any award under the Amended 2019 Plan is deemed to be a
deferred compensation arrangement, and if such arrangement does not comply with Section&nbsp;409A of the Code, the recipient of such
award will recognize ordinary income once such award is vested, as opposed to at the time or times set forth above. In addition, the
amount taxable will be subject to an additional 20% federal income tax along with other potential taxes and penalties. It is intended,
although not guaranteed, that all awards issued under the Amended 2019 Plan will either be exempt from or compliant with the requirements
of Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 8</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2129008d1_posamimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2129008d1_posamimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& 4,# 2(  A$! Q$!_\0
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MO@K0KWP[X6M-.O[Z2[N$&6+-N$>?X%/7:/?]!Q4R4;73*A*=[21T-8FN>+]
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M?R.>U.%K76Y%;FO9O1GMG@?P^_ACPA8:7,RM/&I>8KTWL2Q'OC./PJM\2O\
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@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
